Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare, highly aggressive cancer, often insensitive to conventional chemotherapeutics agents. Early diagnosis, followed by radical surgical resection plus/minus adjuvant mitotane therapy, is nowadays the only valuable option. Unfortunately, one out of four patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiorentini, Chiara, Grisanti, Salvatore, Cosentini, Deborah, Abate, Andrea, Rossini, Elisa, Berruti, Alfredo, Sigala, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463568/
https://www.ncbi.nlm.nih.gov/pubmed/31057613
http://dx.doi.org/10.1155/2019/6072863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463568/
https://www.ncbi.nlm.nih.gov/pubmed/31057613
http://dx.doi.org/10.1155/2019/6072863

Ejemplares similares